You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

5HT2A RO

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Antipsychotics inGeriatric Population: What is Role of

Recruiting
  • Neutropenia
    • Strasbourg, France
      Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
    Oct 27, 2023

    Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

    Not yet recruiting
    • Acneiform Eruption Due to Chemical
    • +2 more
    • HT-001 2% Topical Gel
    • +3 more
    • (no location specified)
    Dec 3, 2022

    Chemo-induced Nausea and Vomiting Trial in Chengdu (5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone)

    Recruiting
    • Chemotherapy-induced Nausea and Vomiting
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 27, 2023

    Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

    Not yet recruiting
    • Healthy
    • Multiple Sclerosis
    • Blood sample
    • Orléans, France
      CHR Orléans
    Feb 16, 2023

    Basic Science Trial in Copenhagen (Psilocybine, Ketanserin)

    Recruiting
    • Basic Science
    • Copenhagen, Denmark
      Neurobiology Research Unit, Rigshospitalet
    Aug 11, 2022

    Tobacco Use Disorder Trial (Psilocybin, Niacin)

    Not yet recruiting
    • Tobacco Use Disorder
    • (no location specified)
    Jul 7, 2022

    Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)

    Not yet recruiting
    • Actinic Keratosis
    • Biopsy
    • +2 more
    • Tucson, Arizona
    • +3 more
    Jan 25, 2023

    Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

    Recruiting
    • Gastric Adenocarcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 20, 2022

    Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

    Not yet recruiting
    • Breast Cancer
    • Chemotherapy-induced Nausea and Vomiting
    • Hanzhou, Zhejiang, China
      the Second Affiliated Hospital of Zhejiang Univercity School of
    Apr 23, 2023

    Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

    Recruiting
    • Metastatic Uveal Melanoma
    • Defactinib Hydrochloride
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 23, 2023

    Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

    Not yet recruiting
    • Clinical Stage I Gastric Cancer AJCC v8
    • +9 more
    • Atezolizumab
    • +12 more
    • (no location specified)
    Apr 26, 2023

    Adverse Effect Trial (normal saline, Ondansetron 4 mg, Ondansetron 8 mg)

    Not yet recruiting
    • Adverse Effect
    • normal saline
    • +2 more
    • (no location specified)
    Jul 25, 2022

    Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

    Recruiting
    • Neurodegenerative Diseases
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 24, 2023

    Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal

    Recruiting
    • Cervical Esophagus Adenocarcinoma
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Cocaine Dependence Trial in Richmond (Mirtazapine 15 MG Oral Tablet)

    Completed
    Has Results
    • Cocaine Dependence
    • Mirtazapine 15 MG Oral Tablet
    • Richmond, Virginia
      Virginia Commonwealth University
    Nov 19, 2021

    Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

    Active, not recruiting
    • Small Cell Carcinoma, Hypercalcaemic Type
    • Ovarian Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Solid Tumors Trial in Worldwide (RO7296682, Atezolizumab)

    Recruiting
    • Solid Tumors
    • Duarte, California
    • +12 more
    Jan 31, 2023

    Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical

    Not yet recruiting
    • Clinical Stage I Esophageal Adenocarcinoma AJCC v8
    • +5 more
    • Biospecimen Collection
    • +9 more
    • Scottsdale, Arizona
    • +2 more
    Oct 11, 2023

    Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

    Recruiting
    • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
    • +10 more
    • Biopsy
    • +8 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 20, 2023

    Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Richter's Transformation
    • Boston, Massachusetts
    • +1 more
    Sep 12, 2023

    Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester

    Not yet recruiting
    • Clinical Stage IV Gastric Cancer AJCC v8
    • +4 more
    • Aldesleukin
    • +10 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 5, 2023

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

    Not yet recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Biospecimen Collection
    • +9 more
    • Los Angeles, California
      Yonemoto,Lisa
    Jan 13, 2023

    Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,

    Active, not recruiting
    • Anal Basaloid Carcinoma
    • +6 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jan 3, 2023

    Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • Placebo
    • Ondansetron Injection
    • Montréal, Quebec, Canada
      Hôpital Sacré-Coeur de Montréal
    Aug 22, 2022

    Solid Tumors Trial in Worldwide (RO7296682)

    Active, not recruiting
    • Solid Tumors
    • Melbourne, Victoria, Australia
    • +10 more
    Jul 11, 2022